These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
719 related items for PubMed ID: 28648527
1. Targeting the Thioredoxin System for Cancer Therapy. Zhang J, Li X, Han X, Liu R, Fang J. Trends Pharmacol Sci; 2017 Sep; 38(9):794-808. PubMed ID: 28648527 [Abstract] [Full Text] [Related]
2. Targeting the Thioredoxin System as a Strategy for Cancer Therapy. Bian M, Fan R, Zhao S, Liu W. J Med Chem; 2019 Aug 22; 62(16):7309-7321. PubMed ID: 30963763 [Abstract] [Full Text] [Related]
3. Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo. Fang J, Holmgren A. J Am Chem Soc; 2006 Feb 15; 128(6):1879-85. PubMed ID: 16464088 [Abstract] [Full Text] [Related]
7. Molecular bases of thioredoxin and thioredoxin reductase-mediated prooxidant actions of (-)-epigallocatechin-3-gallate. Zhang H, Cao D, Cui W, Ji M, Qian X, Zhong L. Free Radic Biol Med; 2010 Dec 15; 49(12):2010-8. PubMed ID: 20951799 [Abstract] [Full Text] [Related]
9. The thioredoxin system and cancer therapy: a review. Mohammadi F, Soltani A, Ghahremanloo A, Javid H, Hashemy SI. Cancer Chemother Pharmacol; 2019 Nov 15; 84(5):925-935. PubMed ID: 31367788 [Abstract] [Full Text] [Related]
10. Small molecule inhibitors of mammalian thioredoxin reductase. Cai W, Zhang L, Song Y, Wang B, Zhang B, Cui X, Hu G, Liu Y, Wu J, Fang J. Free Radic Biol Med; 2012 Jan 15; 52(2):257-65. PubMed ID: 22064364 [Abstract] [Full Text] [Related]
11. Thioredoxin Cross-Linking by Nitrogen Mustard in Lung Epithelial Cells: Formation of Multimeric Thioredoxin/Thioredoxin Reductase Complexes and Inhibition of Disulfide Reduction. Jan YH, Heck DE, Casillas RP, Laskin DL, Laskin JD. Chem Res Toxicol; 2015 Nov 16; 28(11):2091-103. PubMed ID: 26451472 [Abstract] [Full Text] [Related]
12. Securinine disturbs redox homeostasis and elicits oxidative stress-mediated apoptosis via targeting thioredoxin reductase. Zhang J, Yao J, Peng S, Li X, Fang J. Biochim Biophys Acta Mol Basis Dis; 2017 Jan 16; 1863(1):129-138. PubMed ID: 27777067 [Abstract] [Full Text] [Related]
14. Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide. Lu J, Chew EH, Holmgren A. Proc Natl Acad Sci U S A; 2007 Jul 24; 104(30):12288-93. PubMed ID: 17640917 [Abstract] [Full Text] [Related]
15. A thioredoxin reductase and/or thioredoxin system-based mechanism for antioxidant effects of ambroxol. Huang J, Xu J, Tian L, Zhong L. Biochimie; 2014 Feb 24; 97():92-103. PubMed ID: 24103200 [Abstract] [Full Text] [Related]
16. Potential Anticancer Activity of Auranofin. Onodera T, Momose I, Kawada M. Chem Pharm Bull (Tokyo); 2019 Feb 24; 67(3):186-191. PubMed ID: 30827998 [Abstract] [Full Text] [Related]
17. Thioredoxin reductase inhibitors: a patent review. Zhang B, Zhang J, Peng S, Liu R, Li X, Hou Y, Han X, Fang J. Expert Opin Ther Pat; 2017 May 24; 27(5):547-556. PubMed ID: 27977313 [Abstract] [Full Text] [Related]